Patent ID: 9205120
Filing Date: 2015-12-08
Classification: A61K

Abstract:
1. A composition for treating one or more diabetes-related symptoms in a diabetic patient comprising: a therapeutically effective amount of a pomegranate composition, wherein said therapeutically effective amount comprises an amount sufficient to result in significant reduction in oxidative stress in the patient's serum and monocytes-macrophages, as well as in macrophage uptake of Ox-LDL in the patient, wherein said pomegranate composition is obtained by a process comprising: crushing, squeezing, and enzymatically treating whole fruits of pomegranate including the inner and outer peels and seeds to yield a juice component and an insoluble by-product component, separating the juice component from the insoluble by-product component; resuspending the insoluble by-product component in an aqueous medium; crushing, squeezing, and mixing the resuspended by-product component to yield a soluble portion and an insoluble portion; separating the soluble portion from the insoluble portion; and combining the soluble portion with the juice component to produce the pomegranate composition.